Methods of treating non-painful bladder disorders using alpha2delta subunit calcium channel modulators
AssigneeDynogen Pharmaceuticals, Inc.
InventorsKarl Thor, Edward Burgard, Matthew Fraser
Life of this patent
Estimating the term…
Abstract
A method is provided for treatment of non-painful bladder disorders, particularly non-painful overactive bladder without loss of urine. The method comprises administration of an α2δ subunit calcium channel modulator, including gabapentin, pregabalin, GABA analogs, fused bicyclic or tricyclic amino acid analogs of gabapentin, amino acid compounds, and other compounds that interact with the α2δ calcium channel subunit.
Claims4
1-32. (canceled)
A method for treating non-neurogenic overactive bladder where there is not a loss of urine, comprising administering to an individual in need thereof a therapeutically effective amount of a cyclic amino acid compound of formula I
- wherein R1 is hydrogen or lower alkyl;
- n is an integer of from 4 to 6;
- and the cyclic ring is optionally substituted;
- and pharmaceutically acceptable salts thereof.
Dependencies are inferred from the claim text.